Showing results (431-440 of 462) with videos related to
Sort By:
Pageof 47
Oncotarget|December 20, 2015
TGF-β/Smad3 signalling regulates the transition of bone marrow-derived macrophages into myofibroblasts during tissue fibrosisShuang Wang, Xiao-Ming Meng, Yee-Yung Ng, et al.European Journal of Pharmacology|July 5, 2022
Targeted inhibition of TGF-β type I receptor by AZ12601011 protects against kidney fibrosisXiao-Guo Suo, Fang Wang, Chuan-Hui Xu, et al.International Immunopharmacology|September 27, 2022
RIPK3 inhibitor-AZD5423 alleviates acute kidney injury by inhibiting necroptosis and inflammationChuan-Hui Xu, Jia-Nan Wang, Xiao-Guo Suo, et al.International Journal of Biological Sciences|January 29, 2026
Microbiota-Gut-Kidney Axis and Targeted Therapeutic Strategies in Kidney DiseasesZheng-Hao Sun, Qian Gong, Zi-Lai Wang, et al.Science Immunology|September 5, 2025
METTL1-mediated m7G methylation of Sarm1 mRNA promotes macrophage inflammatory responses and multiple organ injuryChao Hou, Xin-Ru Zhang, Jie Wei, et al.Clinical Science (London, England : 1979)|January 4, 2020
Alcohol promotes renal fibrosis by activating Nox2/4-mediated DNA methylation of Smad7Qin Yang, Hai-Yong Chen, Jia-Nan Wang, et al.Redox Biology|March 7, 2020
Smad3 promotes AKI sensitivity in diabetic mice via interaction with p53 and induction of NOX4-dependent ROS productionJia-Nan Wang, Qin Yang, Chen Yang, et al.Acta Pharmacologica Sinica|April 9, 2021
Stratifin promotes renal dysfunction in ischemic and nephrotoxic AKI mouse models via enhancing RIPK3-mediated necroptosisFang Wang, Jia-Nan Wang, Xiao-Yan He, et al.Biochemical Pharmacology|September 7, 2022
Cpd-0225 attenuates renal fibrosis via inhibiting ALK5Shuai-Shuai Xie, Ze-Hui Dong, Yuan He, et al.Nature Communications|December 1, 2025
Renal insulin-like growth factor binding-protein 7 is a critical promoter of progressive diabetic kidney diseaseJu-Tao Yu, Xiao-Wei Hu, Jia-Nan Wang, et al.Pageof 47